NOX5 Antibody

What is NOX5 and why is it significant in scientific research?

NOX5 (NADPH oxidase 5) is a member of the NADPH oxidase family that generates reactive oxygen species (ROS), particularly superoxide, which plays crucial roles in signaling pathways regulating cell proliferation, apoptosis, immune responses, and vascular function. Unlike other NADPH oxidase family members, NOX5 is unique due to its N-terminal region containing EF-hand motifs that bind calcium ions, allowing it to respond directly to intracellular calcium fluctuations . This calcium sensitivity enables direct activation in response to physiological stimuli, making it an important target for research in both physiological and pathological processes. The protein is reported to be approximately 86.4 kilodaltons in mass and is expressed in specific tissues including lymphoid organs and testis, highlighting its importance in both immune system regulation and reproductive biology .

What are the common applications for NOX5 antibodies in research settings?

NOX5 antibodies serve as versatile research tools across multiple experimental platforms. Based on current literature, these antibodies are commonly utilized in:

• Western blot (WB): For detection and quantification of NOX5 protein in cell or tissue lysates

• Immunocytochemistry (ICC): For visualization of NOX5 distribution within cells

• Immunohistochemistry (IHC): For detection of NOX5 in tissue sections

• Immunofluorescence (IF): For detailed subcellular localization studies

• Enzyme-linked immunosorbent assay (ELISA): For quantitative protein detection

• Flow cytometry (FCM): For analysis of NOX5 expression in individual cells

• Immunoprecipitation (IP): For isolation of NOX5 from complex protein mixtures

These diverse applications allow researchers to comprehensively characterize NOX5 expression, localization, and function across various experimental contexts.

What critical factors should be considered when selecting an appropriate NOX5 antibody?

Selecting the optimal NOX5 antibody requires careful consideration of several key parameters:

• Target specificity: Ensure the antibody specifically recognizes NOX5 with minimal cross-reactivity to other NOX family members

• Host species: Consider compatibility with other antibodies if performing co-localization studies

• Clonality: Monoclonal antibodies (like those described in recent publications) offer high specificity for a single epitope, which is particularly important for distinguishing between NOX family members

• Target region: Some antibodies target specific regions (e.g., C-terminal, N-terminal) which may affect detection of specific isoforms

• Validated applications: Verify the antibody has been validated for your intended application (WB, IHC, IF, etc.)

• Species reactivity: Confirm the antibody recognizes NOX5 in your species of interest (human, mouse, etc.)

• Previous citations: Review published literature that has successfully employed the antibody

• Conjugation options: Consider whether your experimental design requires unconjugated antibody or one conjugated to specific tags (HRP, fluorophores, etc.)

Researchers should conduct preliminary validation experiments in their specific experimental system before proceeding with major studies.

How can researchers validate the specificity of NOX5 antibodies?

Rigorous validation of NOX5 antibodies requires a multi-faceted approach:

• Expression system controls:

  • Test antibodies on cells with verified NOX5 overexpression (positive control)

  • Compare with non-transfected or empty vector-transfected cells (negative control)

  • Confirm signal reduction after siRNA/shRNA-mediated knockdown

• Multi-technique validation:

  • Validate across multiple applications (WB, IF, IHC)

  • Compare protein detection results with mRNA expression data

  • Ensure consistency across different detection methods

• Essential controls:

  • Include positive tissue controls (e.g., testis, spleen) where NOX5 expression has been confirmed

  • Use non-specific IgG of the same isotype as negative controls

  • Include appropriate cellular fractionation controls when studying subcellular localization

Recent studies have successfully validated novel monoclonal antibodies against NOX5 using these approaches, demonstrating their ability to detect both heterologously expressed and endogenous NOX5 protein in various applications .

In which human tissues has NOX5 protein expression been definitively demonstrated?

Recent research using validated antibodies has identified NOX5 protein expression in specific human tissues:

• Human spleen: NOX5 protein has been detected, although contrary to initial hypotheses, its expression appears to be of endothelial origin rather than associated with lymphocytes

• Human testis: NOX5 protein localizes predominantly to spermatogenic cells, with highest expression in peripheral cells within the seminiferous tubules

• Human ovary: NOX5 protein expression has been confirmed

• Melanoma cells: Endogenous NOX5 has been detected in UACC-257 melanoma cell lines

Notably, contrary to some previous reports, recent studies using highly specific antibodies found no evidence for NOX5 expression in:

• Mature spermatozoa

• Vascular endothelial and smooth muscle cells

• Lymphocytes or other leukocyte populations

These findings highlight the importance of using validated, specific antibodies for accurate detection of NOX5 in tissues.

What is the subcellular localization pattern of NOX5 and how can it be accurately determined?

NOX5 exhibits specific subcellular localization patterns that can be characterized using appropriate antibody-based techniques:

• Predominant intracellular localization with perinuclear enhancement has been observed in multiple cell types

• Co-localization studies with organelle markers have revealed significant overlap between NOX5 and endoplasmic reticulum (ER) markers, suggesting ER residency as a primary localization for NOX5

For accurate determination of NOX5 subcellular localization:

• Immunofluorescence with confocal microscopy:

  • Use validated NOX5-specific antibodies

  • Perform co-staining with established compartment markers (e.g., ER-targeted fluorescent proteins)

  • Apply appropriate fixation and permeabilization protocols to preserve epitope accessibility

• Subcellular fractionation with Western blotting:

  • Separate cellular components through differential centrifugation

  • Probe fractions with NOX5 antibodies

  • Include fraction-specific markers to confirm purity

• Validation approaches:

  • Demonstrate altered localization patterns after siRNA knockdown

  • Compare localization of endogenous versus overexpressed protein

  • Consider super-resolution microscopy for detailed localization studies

What are the critical parameters for successful Western blot detection of NOX5?

Optimizing Western blot protocols for NOX5 detection requires attention to several specific parameters:

• Sample preparation:

  • Critical: Do not heat samples prior to loading on gels - this is specifically mentioned in the literature as important for NOX5 detection

  • Use fresh lysates when possible

  • Include appropriate protease inhibitors in lysis buffers

  • Load adequate protein (20-40 μg per lane as used in published protocols)

• Gel and transfer conditions:

  • 4-20% Tris glycine gels have been successfully used for NOX5 separation

  • Employ efficient transfer methods (such as I Blot gel transfer stacks)

  • Transfer to nitrocellulose membranes for optimal results

• Blocking and antibody incubation:

  • Block in 1× TBST buffer with 5% nonfat milk for 1 hour at room temperature

  • Incubate with primary antibody overnight in TBST buffer

  • Include appropriate positive controls (e.g., UACC-257 melanoma cells)

• Detection considerations:

  • Look for NOX5 signal around 75-86 kD (NOX5 is reported to be 86.4 kilodaltons)

  • Validate signal using NOX5 siRNA to confirm specificity

  • For enhanced sensitivity, some novel antibodies have demonstrated detection capacity with as few as 1000 cells

Following these optimized conditions facilitates reliable detection of NOX5 by Western blot.

How can researchers distinguish between different NOX5 isoforms?

Distinguishing between NOX5 isoforms (including NOX5α, NOX5β, NOX5γ, NOX5δ, and NOX5ε) requires strategic approaches:

• Isoform discrimination strategies:

  • Utilize antibodies targeting regions that differ between isoforms

  • N-terminal targeting antibodies may distinguish full-length isoforms from truncated variants

  • Compare observed molecular weights with predicted sizes of different isoforms

• Optimized gel conditions:

  • Use high-resolution gels (7.5-8%) for better separation of high-molecular-weight variants

  • Consider gradient gels for simultaneous detection of multiple isoforms

  • Extend running time to enhance separation of closely migrating isoforms

• Validation approaches:

  • Include overexpressed specific isoforms as positive controls (as demonstrated with NOX5β in published studies)

  • Complement antibody detection with RT-PCR using isoform-specific primers

  • Consider immunoprecipitation followed by mass spectrometry for definitive isoform identification

These approaches enable researchers to differentiate between NOX5 isoforms that may have distinct functions and regulatory mechanisms.

How can researchers design experiments to study NOX5's role in ROS production?

Investigating NOX5's functional role in ROS production requires comprehensive experimental design:

• Cell model selection:

  • Utilize cells with endogenous NOX5 expression (e.g., UACC-257 melanoma cells)

  • Alternatively, establish stable cell lines with inducible NOX5 expression

  • Include appropriate control cells (NOX5 knockdown or knockout)

• ROS detection methodology:

  • Employ fluorescent probes specific for superoxide (e.g., dihydroethidium)

  • Implement real-time measurements using plate readers or live-cell imaging

  • Calibrate signals with known ROS generators

• NOX5 activation strategy:

  • Apply calcium-mobilizing agents (thapsigargin, GSK1016790A) as demonstrated in recent studies

  • Use physiologically relevant stimuli known to elevate intracellular calcium

  • Design time-course experiments to capture both immediate and sustained responses

• Validation protocol:

  • Apply NADPH oxidase inhibitors (e.g., DPI) to confirm oxidase dependency

  • Use siRNA to specifically knock down NOX5 (demonstrated to reduce superoxide response)

  • Measure NOX5 protein levels in parallel using validated antibodies

  • Include antioxidants as controls to confirm ROS specificity

This comprehensive approach has been successfully employed to demonstrate calcium-dependent, NOX5-mediated superoxide production in various cell types .

What are the current challenges and contradictions in NOX5 research?

Several significant contradictions exist in the NOX5 research field that require careful methodological consideration:

These contradictions highlight the importance of rigorous methodology and validation in NOX5 research.

How can NOX5 antibodies be employed to investigate pathological processes?

NOX5 antibodies provide valuable tools for investigating various pathological processes:

• Cancer research applications:

  • Characterization of NOX5 expression across different tumor types

  • Analysis of NOX5 localization in tumor tissues

  • Correlation of NOX5 expression with clinical parameters and patient outcomes

• Oxidative stress-related pathologies:

  • Investigation of NOX5 contribution to inflammatory conditions

  • Study of NOX5-mediated ROS production in cardiovascular disorders

  • Analysis of NOX5 involvement in degenerative diseases

• Reproductive pathologies:

  • Examination of NOX5 expression in testicular disorders

  • Investigation of NOX5's role in male infertility conditions

  • Analysis of potential NOX5 dysregulation in ovarian pathologies

• Methodological approaches:

  • Tissue microarray analysis for high-throughput expression profiling across multiple samples

  • Combination with oxidative stress markers to assess functional correlations

  • Integration with clinical data to establish potential diagnostic or prognostic value

These applications represent significant areas where NOX5 antibodies can contribute to understanding disease mechanisms and identifying potential therapeutic targets.

What novel technologies are enhancing NOX5 antibody applications?

Emerging technologies are expanding the capabilities of NOX5 antibody-based research:

• Advanced imaging approaches:

  • Super-resolution microscopy for nanoscale localization studies

  • Multiplexed immunofluorescence for simultaneous detection of multiple markers

  • Live-cell imaging with genetically encoded ROS sensors combined with immunostaining

• Single-cell technologies:

  • Integration of antibody-based detection with single-cell RNA sequencing

  • Mass cytometry (CyTOF) for high-dimensional protein analysis at the single-cell level

  • Spatial transcriptomics combined with immunohistochemistry for contextual analysis

• Proximity-based methods:

  • Proximity ligation assays to detect NOX5 interactions with regulatory proteins

  • FRET-based approaches to study NOX5 activation dynamics

  • BioID or APEX2 proximity labeling to identify novel NOX5-interacting partners

• CRISPR-based approaches:

  • Endogenous tagging of NOX5 for improved antibody detection

  • Knockout/knockin models for antibody validation

  • CRISPRi/CRISPRa systems for controlled expression studies

These technological advances provide researchers with unprecedented tools to study NOX5 with greater precision, sensitivity, and contextual understanding.